113 related articles for article (PubMed ID: 34831445)
1. Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies.
Ma Y; Luk A; Young FP; Lynch D; Chua W; Balakrishnar B; de Souza P; Becker TM
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527157
[TBL] [Abstract][Full Text] [Related]
2. Non-Invasive Profiling of Advanced Prostate Cancer via Multi-Parametric Liquid Biopsy and Radiomic Analysis.
Morrison G; Buckley J; Ostrow D; Varghese B; Cen SY; Werbin J; Ericson N; Cunha A; Lu YT; George T; Smith J; Quinn D; Duddalwar V; Triche T; Goldkorn A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269713
[TBL] [Abstract][Full Text] [Related]
3. Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma.
Chapin WJ; Till JE; Hwang WT; Eads JR; Karasic TB; O'Dwyer PJ; Schneider CJ; Teitelbaum UR; Romeo J; Black TA; Christensen TE; Redlinger Tabery C; Anderson A; Slade M; LaRiviere M; Yee SS; Reiss KA; O'Hara MH; Carpenter EL
JCO Precis Oncol; 2022 Jul; 6():e2200060. PubMed ID: 35939771
[TBL] [Abstract][Full Text] [Related]
4. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer.
Cario CL; Chen E; Leong L; Emami NC; Lopez K; Tenggara I; Simko JP; Friedlander TW; Li PS; Paris PL; Carroll PR; Witte JS
BMC Cancer; 2020 Aug; 20(1):820. PubMed ID: 32859160
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression.
Pimenta R; Malulf FC; Romão P; Caetano GVB; da Silva KS; Ghazarian V; Dos Santos GA; Guimarães V; Silva IA; de Camargo JA; Recuero S; Melão BVLA; Antunes AA; Srougi M; Nahas W; Leite KRM; Reis ST
J Cancer Res Clin Oncol; 2024 Feb; 150(2):70. PubMed ID: 38305916
[TBL] [Abstract][Full Text] [Related]
6. Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer.
Gourdin T; Sonpavde G
Asian J Androl; 2018; 20(3):230-237. PubMed ID: 29578115
[TBL] [Abstract][Full Text] [Related]
7. Detection of Cancer-Associated Gene Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South Africa.
Temilola DO; Wium M; Paccez J; Salukazana AS; Rotimi SO; Otu HH; Carbone GM; Kaestner L; Cacciatore S; Zerbini LF
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895233
[TBL] [Abstract][Full Text] [Related]
8. Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.
Bratic Hench I; Roma L; Conticelli F; Bubendorf L; Calgua B; Le Magnen C; Piscuoglio S; Rubin MA; Chirindel A; Nicolas GP; Vlajnic T; Zellweger T; Templeton AJ; Stenner F; Ruiz C; Rentsch C; Bubendorf L
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201475
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.
Galletti G; Portella L; Tagawa ST; Kirby BJ; Giannakakou P; Nanus DM
Mol Diagn Ther; 2014 Aug; 18(4):389-402. PubMed ID: 24809501
[TBL] [Abstract][Full Text] [Related]
10. Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
Witz A; Dardare J; Betz M; Gilson P; Merlin JL; Harlé A
Clin Exp Med; 2024 Jan; 24(1):2. PubMed ID: 38231464
[TBL] [Abstract][Full Text] [Related]
11. Chemokine releasing particle implants for trapping circulating prostate cancer cells.
Huang Y; Hakamivala A; Li S; Nair A; Saxena R; Hsieh JT; Tang L
Sci Rep; 2020 Mar; 10(1):4433. PubMed ID: 32157115
[TBL] [Abstract][Full Text] [Related]
12. [Individualized precision medicine].
Wullich B; Taubert H; Goebell PJ; Kuwert T; Beck M; Schott C; Baur AS; Eckstein M; Wach S
Urologie; 2023 Sep; 62(9):879-888. PubMed ID: 37526710
[TBL] [Abstract][Full Text] [Related]
13. Experimental in vitro, ex vivo and in vivo models in prostate cancer research.
Sailer V; von Amsberg G; Duensing S; Kirfel J; Lieb V; Metzger E; Offermann A; Pantel K; Schuele R; Taubert H; Wach S; Perner S; Werner S; Aigner A
Nat Rev Urol; 2023 Mar; 20(3):158-178. PubMed ID: 36451039
[TBL] [Abstract][Full Text] [Related]
14. Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients.
Lieb V; Abdulrahman A; Weigelt K; Hauch S; Gombert M; Guzman J; Bellut L; Goebell PJ; Stöhr R; Hartmann A; Wullich B; Taubert H; Wach S
Cells; 2022 Nov; 11(22):. PubMed ID: 36429046
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients.
Lieb V; Abdulrahman A; Weigelt K; Hauch S; Gombert M; Guzman J; Bellut L; Goebell PJ; Stöhr R; Hartmann A; Wullich B; Taubert H; Wach S
Cells; 2021 Nov; 10(11):. PubMed ID: 34831445
[TBL] [Abstract][Full Text] [Related]
16. Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer.
Fettke H; Kwan EM; Docanto MM; Bukczynska P; Ng N; Graham LK; Mahon K; Hauser C; Tan W; Wang XH; Zhao Z; Zheng T; Zhou K; Du P; Yu J; Huang Y; Jia S; Kohli M; Horvath LG; Azad AA
Eur Urol; 2020 Aug; 78(2):173-180. PubMed ID: 32487321
[TBL] [Abstract][Full Text] [Related]
17. A novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients.
García JL; Lozano R; Misiewicz-Krzeminska I; Fernández-Mateos J; Krzeminski P; Alfonso S; Marcos RA; García R; Gómez-Veiga F; Virseda Á; Herrero M; Olmos D; Cruz-Hernández JJ
Clin Transl Oncol; 2017 Nov; 19(11):1350-1357. PubMed ID: 28600675
[TBL] [Abstract][Full Text] [Related]
18. Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
Antonarakis ES; Lu C; Luber B; Wang H; Chen Y; Nakazawa M; Nadal R; Paller CJ; Denmeade SR; Carducci MA; Eisenberger MA; Luo J
JAMA Oncol; 2015 Aug; 1(5):582-91. PubMed ID: 26181238
[TBL] [Abstract][Full Text] [Related]
19. Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer.
Zhang T; Karsh LI; Nissenblatt MJ; Canfield SE
Clin Genitourin Cancer; 2020 Feb; 18(1):1-10. PubMed ID: 31653572
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
